严重瘤颈成角患者标准血管内动脉瘤修复术的远期结局
该回顾性病例对照研究基于前瞻性多中心数据库,比较严重瘤颈成角组(45例)与匹配对照组(65例)接受标准EVAR的远期结局,中位随访7.4年。7年时成角组IA型内漏发生率高于对照组,但死亡率未受明显影响;作者认为对极度成角患者应审慎使用EVAR并加强远期随访。
要点
- 严重瘤颈成角患者EVAR术后7年免于IA型内漏率为86.1%,对照组为96.6%(P = .056)。
- 排除1例继发于移植物感染的IA型内漏后,成角组与对照组差异显著(86.1% vs 98.2%,P = .016)。
- 7年总生存率成角组44.3% vs 对照组66.7%(P = .25),死亡率未受内漏差异影响。
核心结论
- 尽管早期和中期结果满意,远期严重瘤颈成角患者IA型内漏发生率更高,但死亡率未受该差异影响。
- 作者认为对近端瘤颈极度成角的患者应审慎使用EVAR,并强调EVAR术后密切随访的必要性,尤其是远期和超说明书使用患者。
研究设计与样本
- 回顾性病例对照研究,基于前瞻性多中心数据库,所有测量采用专用软件结合中心腔线重建完成。
- 成角组纳入瘤颈长度>15 mm且肾下角(β)>75度或肾上角(α)>60度,或瘤颈长度10–15 mm且β>60度或α>45度的患者,共45例。
- 对照组按人口学特征及其他瘤颈形态特征匹配,共65例。
- 主要终点为IA型内漏(EL1A);次要终点为免于瘤颈相关二次干预、主要临床成功和总生存率。
主要发现
- 中位随访7.4年(四分位距4.8–8.5年)。
- 成角组平均α为51.4度(±21.1度)、平均β为80.8度(±15.6度);非成角组分别为17.9度(±17.0度)和35.4度(±20.0度)。
- 7年时成角组5例、非成角组2例发生EL1A,免于EL1A率分别为86.1%(n = 14;标准误0.069)和96.6%(n = 34;标准误0.023),P = .056。
- 排除1例继发于移植物感染的EL1A后,成角组免于EL1A率为86.1%(n = 14;标准误0.069),非成角组为98.2%(n = 34;标准误0.018),P = .016。
- 7年免于瘤颈相关二次干预率成角组为91.7%(n = 14;标准误0.059),非成角组为91.6%(n = 29;标准误0.029)。
临床怎么用
- 作者认为,对近端瘤颈极度成角的患者应审慎使用EVAR,并强调EVAR术后密切随访的必要性,尤其是远期和超说明书使用患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Severe neck angulation is associated with complications after endovascular aneurysm repair (EVAR). Newer endografts may overcome this limitation, but the literature lacks long-term results. We studied the long-term outcomes of EVAR in patients with severe neck angulation. METHODS: A retrospective case-control study of a prospective multicenter database was performed. All measurements were made with dedicated software with center lumen line reconstruction. A study group including patients with neck length >15 mm, infrarenal angle (β) >75 degrees or suprarenal angle (α) >60 degrees, and neck length 10 to 15 mm with β >60 degrees or α >45 degrees was compared with a control group matched for demographics and other morphologic neck features. The primary end point was type IA endoleak (EL1A). Secondary end points were freedom from neck-related secondary interventions, primary clinical success, and overall survival. RESULTS: Forty-five patients were included in the angulated neck group and compared with 65 matched patients. Median follow-up was 7.4 years (interquartile range, 4.8-8.5 years). In the angulated neck group, mean α was 51.4 degrees (±21.1 degrees) and the mean β was 80.8 degrees (±15.6 degrees); in the nonangulated group, these were 17.9 degrees (±17.0 degrees) and 35.4 degrees (±20.0 degrees), respectively. At 7 years, five patients in the angulated neck group and two nonangulated patients developed EL1A, yielding a freedom from EL1A of 86.1% (n = 14; standard error [SE], 0.069) and 96.6% (n = 34; SE, 0.023), respectively (P = .056). After exclusion of a patient who developed an EL1A secondary to an endograft infection, this difference was significant: 86.1% (n = 14; SE, 0.069) in the angulated neck group and 98.2% (n = 34; SE, 0.018) in the nonangulated group (P = .016). At 7 years, freedom from neck-related secondary interventions was 91.7% (n = 14; SE, 0.059) and 91.6% (n = 29; SE, 0.029), respectively. The 7-year primary clinical success estimates were 41.2% (n = 11; SE, 0.085) and 56.6% (n = 20; SE, 0.072) for the angulated neck and nonangulated groups, respectively (P = .12). The 7-year survival rates were 44.3% (n = 18; SE, 0.076) vs 66.7% (n = 42; SE, 0.059) for the angulated neck and nonangulated groups, respectively (P = .25). Device integrity failure was not observed. CONCLUSIONS: Despite satisfactory results early and in the midterm, a higher rate of EL1A was identified among patients with severely angulated necks in the long term. However, mortality was not affected by this difference. These findings suggest that EVAR should be used judiciously in patients with extreme angulation of the proximal neck and highlight the need for close follow-up of EVAR, especially in the long term and in patients treated outside instructions for use.
引用
- Oliveira NFG, Gonçalves FB, Hoeks SE, et al. Long-term outcomes of standard endovascular aneurysm repair in patients with severe neck angulation. J Vasc Surg. 2018. PMID: 29914837. doi:10.1016/j.jvs.2018.03.427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。